4 completed, 1 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Terminated 1 |
Follow NX-1207: new trials by email Literature Review of NX-1207 trials Research Report on NX-1207
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH NX-1207, Tamsulosin - Lower Urinary Tract Symptoms | Phase 3 | Terminated | RECORDATI GROUP | 104 | 2013-09-01 | 2022-05-26 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) NX-1207 - Benign Prostatic Hyperplasia, BPH | Phase 3 | Completed | Nymox Corporation | 160 | 2013-04-01 | 2017-03-10 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX-1207 - Benign Prostatic Hyperplasia | Phase 3 | Completed | Nymox Corporation | 192 | 2011-09-01 | 2014-04-30 |
| Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 NX-1207, Placebo - Benign Prostatic Hyperplasia (BPH) | Phase 3 | Completed | Nymox Corporation | 500 | 2009-05-01 | 2017-03-10 |
| Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX-1207, Placebo - Benign Prostatic Hyperplasia | Phase 3 | Completed | Nymox Corporation | 500 | 2009-04-01 | 2014-04-30 |
Prostatic Hyperplasia (4) · Lower Urinary Tract Symptoms (3) · Urinary Bladder Neck Obstruction (2)
Nymox Corporation (4) · RECORDATI GROUP (1)
United States (4) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1)